Metraipolis › archive › dc_cba72a7fcf93
The efficacy and safety of remimazolam for the management of emergence agitation: a randomized, double-blind, placebo-controlled study — Europe PMC PMID:40904354
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40904354
- DOI
- 10.3389/fmed.2025.1612779
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T12:03:52.699Z
- SHA-256 of the archived text
f0f2396885662b4490262f83cfea04730fb022ca07cf77cd5e31581fb66c5abf- Stable URL of this page
https://metraipolis.com/documento/dc_cba72a7fcf93
How to cite
The efficacy and safety of remimazolam for the management of emergence agitation: a randomized, double-blind, placebo-controlled study — Europe PMC PMID:40904354 — Europe PMC (en), https://europepmc.org/article/MED/40904354 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cba72a7fcf93 (Metraipolis archive dc_cba72a7fcf93, sha256 f0f2396885662b4490262f83cfea04730fb022ca07cf77cd5e31581fb66c5abf)
BibTeX
@misc{dccba72a7fcf93,
title = {The efficacy and safety of remimazolam for the management of emergence agitation: a randomized, double-blind, placebo-controlled study — Europe PMC PMID:40904354},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40904354},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cba72a7fcf93; sha256 f0f2396885662b4490262f83cfea04730fb022ca07cf77cd5e31581fb66c5abf},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40904354. Agents can read the archived copy with the MCP tool read_document.